OKYO Pharma Limited Stock London S.E.
Equities
OKYO
GG00BMFG5F62
Pharmaceuticals
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 48.08M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | -15M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.62
x | P/E ratio 2025 * |
-3.81
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.63% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Jacob
CEO | Chief Executive Officer | 77 | 21-01-06 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | 20-07-31 |
William Clementi
COO | Chief Operating Officer | - | 23-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-09 |
Willy Simon
BRD | Director/Board Member | 72 | 15-05-31 |
Gabriele Cerrone
CHM | Chairman | 52 | 21-01-06 |
1st Jan change | Capi. | |
---|---|---|
-4.66% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+55.89% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+4.12% | 8.75B |